Dr Beth Ann Zavell, MD | |
12780 Roachton Road, #1, Perrysburg, OH 43551 | |
(419) 872-0777 | |
(419) 872-2369 |
Full Name | Dr Beth Ann Zavell |
---|---|
Gender | Female |
Speciality | Dermatology |
Experience | 34 Years |
Location | 12780 Roachton Road, Perrysburg, Ohio |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1225031933 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207N00000X | Dermatology | 35066622Z (Ohio) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Promedica Toledo Hospital | Toledo, OH | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Dermatology Associates Inc | 7113092917 | 14 |
News Archive
Researchers at the University of Copenhagen, Herlev Hospital and Rigshospitalet have identified a clear link between narrowed heart valves and a special lipoprotein in the blood. In the long term, the research may well help to prevent valvular heart disease.
The U.S. Food and Drug Administration yesterday granted accelerated approval to the checkpoint inhibitor Bavencio (avelumab) for the treatment of patients with metastatic Merkel cell carcinoma (MCC), including those who have not received prior chemotherapy.
Patients unable to breathe because of acute lung failure or an obstructed airway need another way to get oxygen to their blood—and fast—to avoid cardiac arrest and brain injury. A team led by researchers at Boston Children's Hospital has designed tiny, gas-filled microparticles that can be injected directly into the bloodstream to quickly oxygenate the blood.
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
MorphoSys AG today announced updated clinical data on its proprietary drug candidate MOR208. MOR208 is a potent anti-CD19 antibody with a proprietary modification to the Fc portion that is being developed to treat B-cell malignancies.
› Verified 1 days ago
Entity Name | Dermatology Associates Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1962578393 PECOS PAC ID: 7113092917 Enrollment ID: O20080813000451 |
News Archive
Researchers at the University of Copenhagen, Herlev Hospital and Rigshospitalet have identified a clear link between narrowed heart valves and a special lipoprotein in the blood. In the long term, the research may well help to prevent valvular heart disease.
The U.S. Food and Drug Administration yesterday granted accelerated approval to the checkpoint inhibitor Bavencio (avelumab) for the treatment of patients with metastatic Merkel cell carcinoma (MCC), including those who have not received prior chemotherapy.
Patients unable to breathe because of acute lung failure or an obstructed airway need another way to get oxygen to their blood—and fast—to avoid cardiac arrest and brain injury. A team led by researchers at Boston Children's Hospital has designed tiny, gas-filled microparticles that can be injected directly into the bloodstream to quickly oxygenate the blood.
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
MorphoSys AG today announced updated clinical data on its proprietary drug candidate MOR208. MOR208 is a potent anti-CD19 antibody with a proprietary modification to the Fc portion that is being developed to treat B-cell malignancies.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Beth Ann Zavell, MD 12780 Roachton Road, #1, Perrysburg, OH 43551 Ph: (419) 872-0777 | Dr Beth Ann Zavell, MD 12780 Roachton Road, #1, Perrysburg, OH 43551 Ph: (419) 872-0777 |
News Archive
Researchers at the University of Copenhagen, Herlev Hospital and Rigshospitalet have identified a clear link between narrowed heart valves and a special lipoprotein in the blood. In the long term, the research may well help to prevent valvular heart disease.
The U.S. Food and Drug Administration yesterday granted accelerated approval to the checkpoint inhibitor Bavencio (avelumab) for the treatment of patients with metastatic Merkel cell carcinoma (MCC), including those who have not received prior chemotherapy.
Patients unable to breathe because of acute lung failure or an obstructed airway need another way to get oxygen to their blood—and fast—to avoid cardiac arrest and brain injury. A team led by researchers at Boston Children's Hospital has designed tiny, gas-filled microparticles that can be injected directly into the bloodstream to quickly oxygenate the blood.
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
MorphoSys AG today announced updated clinical data on its proprietary drug candidate MOR208. MOR208 is a potent anti-CD19 antibody with a proprietary modification to the Fc portion that is being developed to treat B-cell malignancies.
› Verified 1 days ago
Dr. Hope Terecia Mitchell, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 815 Commerce Dr, Perrysburg, OH 43551 Phone: 419-871-3737 Fax: 419-873-8329 | |
Dr. Sarah Campbell Stierman, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 12780 Roachton Rd # 1, Perrysburg, OH 43551 Phone: 419-872-0777 | |
Dana Lynn Sachs, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 12780 Roachton Rd, Perrysburg, OH 43551 Phone: 419-872-0777 | |
Brynn Charlotte Krukemyer, PA-C Dermatology Medicare: Medicare Enrolled Practice Location: 900 W South Boundary St, Perrysburg, OH 43551 Phone: 419-873-6963 | |
Dr. Christy Ann Lorton, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 12780 Roachton Rd #1, Perrysburg, OH 43551 Phone: 419-872-0777 Fax: 419-872-2369 | |
Dr. Abdel Kader Tal, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 900 W South Boundary St Bldg 9a, Perrysburg, OH 43551 Phone: 419-873-6963 Fax: 419-873-6964 |